Horneff, Gerd <br/><br/>
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.  [electronic resource] 

 -  Annals of the rheumatic diseases  Jun 2014 
 - 1114-22 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2012-203046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Juvenile--drug therapy<br/>Arthritis, Psoriatic--drug therapy<br/>Child<br/>Child, Preschool<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Male<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Severity of Illness Index<br/>Treatment Outcome